688026.SHG Guangzhou Jet Bio-Filtration Co Ltd
- Market cap
- CNY 3.31B
- P/E
- 138.8x
- P/B
- 2.45x
- ROE
- 3.8%
- Dividend yield
- 0.44%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 688026.SHG undervalued?
Graham numberThe Graham number of Guangzhou Jet Bio-Filtration Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Guangzhou Jet Bio-Filtration Co Ltd fundamental analysis
No fundamental analysis for Guangzhou Jet Bio-Filtration Co Ltd yet.
Guangzhou Jet Bio-Filtration Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Guangzhou Jet Bio-Filtration Co Ltd
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration, molecular biology, cellsafe, medical consumables, biological reagents, medical devices, laboratory instruments, and customization services. The company was founded in 2001 and is headquartered in Guangzhou, China.
Full company profileGuangzhou Jet Bio-Filtration Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Guangzhou Jet Bio-Filtration Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 124M | 167M | 207M | 247M | 504M | 856M | 610M | 463M | 559M | 565M | 567M |
| Gross Profit | 53.8M | 75.9M | 91.7M | 111M | 233M | 359M | 194M | 142M | 231M | 61.3M | 227M |
| Operating Income | 24.5M | 43.5M | 61.2M | 76.4M | 148M | 211M | 96.1M | 39.4M | 95.7M | 61.3M | 94.4M |
| EBITDA | 34.0M | 49.6M | 71.7M | 88.4M | 170M | 249M | 174M | 98.0M | 168M | 120M | 82.9M |
| Net Income | 26.1M | 40.4M | 52.8M | 66.2M | 119M | 171M | 87.7M | 34.8M | 72.2M | 48.2M | 45.5M |
| EPS | 0.61 | 0.41 | 0.54 | 0.47 | 0.85 | 1.22 | 0.62 | 0.25 | 0.52 | 0.35 | 0.32 |
| Balance Sheet | |||||||||||
| Total Assets | 202M | 230M | 328M | 397M | 970M | 1.18B | 1.61B | 1.63B | 1.70B | 1.74B | 1.75B |
| Total Liabilities | 55.9M | 44.0M | 46.3M | 49.3M | 173M | 209M | 465M | 468M | 505M | 516M | 532M |
| Shareholders' Equity | 146M | 186M | 282M | 348M | 797M | 972M | 1.14B | 1.16B | 1.19B | 1.22B | 1.21B |
| Cash & Short-term Investments | 19.9M | 19.3M | 32.4M | 76.1M | 357M | 263M | 599M | 539M | 459M | 348M | 370M |
| Total Debt | 21.0M | - | - | - | 12.3M | 47.2M | 322M | 340M | 360M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 33.4M | 46.7M | 45.1M | 61.0M | 188M | 221M | 166M | 135M | 54.0M | 192M | - |
| Capital Expenditure | 9.79M | 12.5M | 26.5M | 55.2M | 251M | 279M | 173M | 184M | 111M | 124M | 58.6M |
| Free Cash Flow | 23.6M | 34.2M | 18.6M | 5.85M | -63.3M | -57.5M | -7.00M | -48.9M | -56.7M | 67.7M | 48.3M |
| Ratios | |||||||||||
| ROE | 17.9% | 21.7% | 18.7% | 19.0% | 15.0% | 17.6% | 7.7% | 3.0% | 6.1% | 4.0% | 3.8% |
| ROA | 12.9% | 17.6% | 16.1% | 16.6% | 12.3% | 14.5% | 5.5% | 2.1% | 4.2% | 2.8% | 2.6% |
| Net Profit Margin | 21.0% | 24.2% | 25.5% | 26.7% | 23.7% | 20.0% | 14.4% | 7.5% | 12.9% | 8.5% | 8.0% |
| Debt to Equity | 0.14x | - | - | - | 0.02x | 0.05x | 0.28x | 0.29x | 0.30x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Guangzhou Jet Bio-Filtration Co Ltd dividends
- Dividend yield
- 0.44%
- Forward dividend
- 0.07 CNY
- Payout ratio
- 30.0%
- Ex-dividend date
- Jul 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 14.4M | 0.10 | 30.0% |
| 2024 | CNY 12.3M | 0.09 | 17.1% |
| 2023 | CNY 11.3M | 0.08 | 32.5% |
| 2022 | CNY 60.0M | 0.43 | 68.4% |
| 2021 | CNY 12.3M | 0.09 | 7.2% |
| 2020 | CNY 50.0M | 0.36 | 41.9% |
| 2019 | - | - | - |
| 2018 | 12.5M | 0.13 | 23.6% |
| 2017 | 870K | 0.01 | 2.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 8, 2022.
Who owns Guangzhou Jet Bio-Filtration Co Ltd
- Insiders 47.53%
- Institutions 4.70%
- Public & others 47.77%
- Shares outstanding 140M
- Free float 69.1M
Guangzhou Jet Bio-Filtration Co Ltd company profile
- Company name
- Guangzhou Jet Bio-Filtration Co Ltd
- Ticker
- 688026.SHG
- ISIN
- CNE100003RQ9
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,028
- Fiscal year end
- December
- Address
- No. 1 Doutang Road, Guangzhou, China, 511356
- Phone
- 86 20 3281 1888
- Website
- jetbiofil.com
About Guangzhou Jet Bio-Filtration Co Ltd
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration, molecular biology, cellsafe, medical consumables, biological reagents, medical devices, laboratory instruments, and customization services. The company was founded in 2001 and is headquartered in Guangzhou, China.
Guangzhou Jet Bio-Filtration Co Ltd management
8- Mr. Jianhua YuanChairman & Chief Scientist · born 1952
- Mr. Ye YuanGM & Director · born 1979
- Mr. Feng XieChief Financial Officer · born 1980
- Mr. Xiangyuan FangChief Engineer, Engineering Department Manager & Director of the R&D Center · born 1972
- Ms. Jing HeDeputy GM & Director · born 1988
- Ms. Huilun LiDeputy General Manager · born 1981
- Yong An WuAccounting Officer
- Mr. Zhiyi WuDeputy General Manager · born 1974